{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:24:25Z","timestamp":1789205065106,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.biomaterials.2009.12.042","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T05:45:47Z","timestamp":1262756747000},"page":"2874-2881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis"],"prefix":"10.1016","volume":"31","author":[{"given":"Huaying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2009.12.042_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14656566.9.4.551","article-title":"Epidemiology and management of cryptococcal meningitis: developments and challenges","volume":"9","author":"Pukkila-Worley","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/1061186031000115150","article-title":"The study on brain targeting of the amphotericin B liposomes","volume":"11","author":"Zhang","year":"2003","journal-title":"J Drug Target"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development","volume":"44","author":"Groll","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/apc.2006.20.227","article-title":"Emergence of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after treatment for Cryptococcus neoformans meningitis in a patient with AIDS","volume":"20","author":"Manfredi","year":"2006","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1568005024605855","article-title":"Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics","volume":"2","author":"Hancock","year":"2002","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00109-006-0143-4","article-title":"Multifunctional antimicrobial peptides: therapeutic targets in several human diseases","volume":"85","author":"Zaiou","year":"2007","journal-title":"J Mol Med"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/092986608783744252","article-title":"Host defense peptides and the new line of defence against multiresistant infections","volume":"15","author":"Hirsch","year":"2008","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijantimicag.2005.02.003","article-title":"Clinical development of antimicrobial peptides","volume":"25","author":"Andr\u00e8s","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.21053","article-title":"Research advances in the development of peptide antibiotics","volume":"97","author":"Rossi","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S1466252308001497","article-title":"Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics","volume":"9","author":"Sang","year":"2008","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/psc.914","article-title":"Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules","volume":"14","author":"Cabras","year":"2008","journal-title":"J Pept Sci"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dkl382","article-title":"Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts","volume":"58","author":"Benincasa","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","article-title":"Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers","volume":"60","author":"Torchilin","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1166\/jbn.2006.036","article-title":"Trans-activating transcriptional activator (TAT) peptide-mediated brain drug delivery","volume":"2","author":"Rao","year":"2006","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nnano.2009.153","article-title":"Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent","volume":"4","author":"Liu","year":"2009","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents: chemotherapeutic targets and immunologic strategies","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/AAC.41.3.706","article-title":"Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis","volume":"41","author":"Luna","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/AAC.48.2.384-387.2004","article-title":"In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans","volume":"48","author":"Miller","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib23","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/AAC.40.8.1910","article-title":"In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans","volume":"40","author":"Perfect","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib24","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/AAC.00085-07","article-title":"New guinea pig model of Cryptococcal meningitis","volume":"51","author":"Kirkpatrick","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbamem.2006.02.021","article-title":"Peptide\u2013membrane interactions and mechanisms of membrane destruction by amphipathic \u03b1-helical antimicrobial peptides","volume":"1758","author":"Sato","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/138955707780619563","article-title":"Rational design of vector and antibiotic peptides using solid-state NMR","volume":"7","author":"Mason","year":"2007","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.bbamem.2006.07.001","article-title":"Detergent-like actions of linear amphipathic cationic antimicrobial peptides","volume":"1758","author":"Bechinger","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(01)00092-5","article-title":"Cationic peptides: effectors in innate immunity and novel antimicrobials","volume":"1","author":"Hancock","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F","article-title":"Mode of action of linear amphipathic alpha-helical antimicrobial peptides","volume":"47","author":"Oren","year":"1998","journal-title":"Biopolymers"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2796.2003.01228.x","article-title":"Antibacterial peptides: basic facts and emerging concepts","volume":"254","author":"Boman","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib32","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.0701453104","article-title":"Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins","volume":"104","author":"Cho","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib33","first-page":"177","article-title":"Chronic cryptococcal meningitis: a new experimental model in rabbits","volume":"101","author":"Perfect","year":"1980","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biomaterials.2009.12.042_bib34","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/AAC.33.10.1735","article-title":"Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304","volume":"33","author":"Perfect","year":"1989","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296120901429X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296120901429X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:17:08Z","timestamp":1758899828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296120901429X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S014296120901429X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2009.12.042","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2111961.1706060","asserted-by":"object"}]},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2009.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}